Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamic Medical TechnologiesROCO:4138 -0.95%82 Debt-to-EBITDA is 1.03 as of Jun. 2026, which is 6% above its 10-year median of 0.97. GuruFocus rates ROCO:4138 with a GF Score™ of 82/100 and a GF Value™ of NT$72.57 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 475 Medical Devices & Instruments companies, Dynamic Medical Technologies ranks better than 57.47% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Dynamic Medical Technologies's Debt-to-EBITDA or its related term are showing as below:
ROCO:4138'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.68 Med: 0.97 Max: 1.38
Current: 1.08
During the past 13 years, the highest Debt-to-EBITDA Ratio of Dynamic Medical Technologies was 1.38. The lowest was 0.68. And the median was 0.97.
ROCO:4138's Debt-to-EBITDA is ranked better than 57.47% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 1.63
vs ROCO:4138: 1.08
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Dynamic Medical Technologies Debt-to-EBITDA Related Terms
Dynamic Medical Technologies Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4138 vs ABT, SYK, MDT: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Dynamic Medical Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamic Medical Technologies Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dynamic Medical Technologies's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Dynamic Medical Technologies (ROCO:4138) has a Debt-to-EBITDA of 1.03 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dynamic Medical Technologies. This is near median its historical median of 0.97. Over the past decade, Dynamic Medical Technologies' Debt-to-EBITDA has ranged from 0.68 to 1.38. According to the industry distribution chart, Dynamic Medical Technologies ranks #202 out of 475 companies in the Medical Devices & Instruments industry, placing it in the top 42.5%.
Is Dynamic Medical Technologies' Debt-to-EBITDA too high?
Dynamic Medical Technologies' current Debt-to-EBITDA of 1.03 is near median its 10-year median of 0.97. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 1.38. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.63. Dynamic Medical Technologies' value of 1.03 is 36.8% below this industry median. Based on the distribution chart, Dynamic Medical Technologies ranks #202 out of 475 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dynamic Medical Technologies has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' Debt-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Dynamic Medical Technologies ranks #202 out of 475 companies for Debt-to-EBITDA. This puts Dynamic Medical Technologies in the upper half of its industry. The industry median Debt-to-EBITDA is 1.63. Dynamic Medical Technologies' value of 1.03 is 36.8% below this benchmark. Historically, Dynamic Medical Technologies' own Debt-to-EBITDA has ranged from 0.68 to 1.38 over the past decade. While the company's 10-year median is 0.97 vs. the industry median of 1.63, Dynamic Medical Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.63, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamic Medical Technologies's current Debt-to-EBITDA of 1.03 is 36.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dynamic Medical Technologies. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamic Medical Technologies's current Debt-to-EBITDA is 1.03, which is near median its own 10-year median of 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$72.57, compared to a current price of NT$52.30 — trading 27.9% below its estimated fair value. The current Debt-to-EBITDA is 1.03, which is near median its 10-year median of 0.97 and 36.8% below the Medical Devices & Instruments industry median of 1.63. Dynamic Medical Technologies' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current Debt-to-EBITDA is 1.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?
Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued.
The current stock price of NT$52.30 is trading 27.9% below its estimated GF Value™ of NT$72.57.
GuruFocus considers Dynamic Medical Technologies to be Modestly Undervalued.
Key valuation signals for ROCO:4138:
Debt-to-EBITDA: 1.03 (near median its 10-year median of 0.97)
GF Value™: NT$72.57 vs. price of NT$52.30 (27.9% below fair value)
Industry Position: 36.8% below the Medical Devices & Instruments median (#202 of 475)
No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
82GF Score
Get the complete analysis for ROCO:4138
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4138 has been successfully added to your 
